Managing type 2 diabetes often involves escalating insulin doses to maintain glycemic control, a strategy associated with weight gain and increased hypoglycemia risk. Emerging evidence indicates that acupuncture may offer a non-pharmacological adjunct to reduce insulin dependency in this patient population.
Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and progressive beta-cell dysfunction, necessitating exogenous insulin therapy for many patients.1 While effective in controlling hyperglycemia, high-dose insulin regimens are associated with adverse effects including weight gain, increased risk of hypoglycemia, and potential for treatment burden.2 The search for adjunctive therapies that can mitigate these challenges and potentially reduce insulin requirements is ongoing. Traditional Chinese medicine, specifically acupuncture, has been explored for its potential metabolic benefits, including effects on glucose metabolism and insulin sensitivity.3
Acupuncture's Role in Glycemic Control
Acupuncture involves the insertion of fine needles into specific points on the body, known as acupoints, to stimulate physiological responses.4 In the context of T2DM, proposed mechanisms include modulation of the autonomic nervous system, reduction of inflammation, and improvement of insulin signaling pathways.5 Several studies have investigated the impact of acupuncture on various parameters of T2DM, including fasting blood glucose, HbA1c, and insulin sensitivity.6
A meta-analysis of randomized controlled trials (RCTs) examining acupuncture as an adjunct to conventional T2DM treatment included 15 studies with a total of 1,250 participants.7 The primary outcome was the change in daily insulin dosage. Patients in the acupuncture groups received treatment for an average of 8 to 12 weeks, typically with 2 to 3 sessions per week.7 Control groups received either sham acupuncture, standard care alone, or lifestyle interventions.7
The analysis revealed that patients receiving true acupuncture experienced a statistically significant reduction in daily insulin dosage compared to control groups (weighted mean difference: -5.2 units/day, 95% CI: -6.8 to -3.6 units/day, p < 0.001).7 This reduction was observed across studies regardless of baseline insulin dose or duration of T2DM.7 Furthermore, a secondary outcome indicated a modest but significant improvement in fasting blood glucose levels (weighted mean difference: -0.8 mmol/L, 95% CI: -1.1 to -0.5 mmol/L, p < 0.001) and HbA1c (weighted mean difference: -0.4%, 95% CI: -0.6% to -0.2%, p < 0.001) in the acupuncture groups.7 The incidence of hypoglycemic events was not significantly different between the acupuncture and control groups.7
Limitations of the current evidence base include heterogeneity in acupuncture protocols, such as variations in acupoint selection, treatment duration, and needle stimulation techniques.8 The quality of blinding in some sham-controlled trials also presents a challenge, as participants may infer treatment allocation.8 Additionally, most studies were conducted in Asian populations, which may limit generalizability to other ethnic groups.8 Future research should focus on standardizing acupuncture protocols, conducting larger multicenter trials with longer follow-up periods, and elucidating the precise physiological mechanisms underlying acupuncture's effects on glucose metabolism.9
The data on acupuncture's ability to reduce insulin requirements in type 2 diabetes patients is compelling, offering a potential non-pharmacological strategy to mitigate the burden of high-dose insulin therapy. For clinicians managing patients with escalating insulin needs, particularly those struggling with weight gain or recurrent hypoglycemia, considering acupuncture as an adjunctive therapy could be a pragmatic step. However, the lack of standardized protocols and the variability in study designs mean that integrating acupuncture into mainstream diabetes management guidelines, such as those from the American Diabetes Association or NICE, remains premature. Referral pathways and reimbursement policies would also need to evolve to support such an integration.
From a patient perspective, a therapy that promises to reduce daily insulin injections and potentially improve glycemic control without additional pharmaceutical side effects is highly attractive. This could enhance treatment adherence and overall quality of life. However, patients must be educated on the evidence base, understanding that acupuncture is a complementary therapy and not a replacement for established pharmacological treatments. The cost and accessibility of qualified acupuncture practitioners also present practical barriers that need to be addressed for broader adoption.
The pharmaceutical industry, while not directly impacted by a non-pharmacological intervention, should monitor this evolving evidence. Any widespread adoption of acupuncture could subtly shift prescribing patterns for insulin and other glucose-lowering agents, particularly in patients seeking alternatives or adjuncts to conventional drug regimens. Investment in research to understand the synergistic effects of acupuncture with existing pharmacotherapies, or even its potential to delay treatment escalation, could be a strategic consideration. The challenge for all stakeholders will be to move beyond anecdotal evidence and integrate rigorous, standardized research into clinical practice.
- The Pivot Acupuncture, traditionally used for pain management, is now being investigated for its role in metabolic regulation in type 2 diabetes.
- The Data Patients receiving acupuncture demonstrated a significant reduction in daily insulin dosage compared to control groups.
- The Action Clinicians may consider acupuncture as a complementary therapy for type 2 diabetes patients struggling with high insulin requirements, though further standardization is needed.
ART-2026-282
Cite This Article
Team TLSFE. Acupuncture reduces insulin needs in type 2 diabetes. The Life Science Feed. Updated June 11, 2026. Accessed June 11, 2026. https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/research/acupuncture-reduces-insulin-needs-in-type-2-diabetes.
Licence & Rights
© 2026 The Life Science Feed. All rights reserved. Unless otherwise indicated, all content is the property of The Life Science Feed and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission.
Medical Disclaimer
Editorial & AI Standards
All content is researched from peer-reviewed, open-access sources — published trial data, clinical guidelines, and regulatory filings. AI tools are used solely to structure and summarise that evidence; no AI-generated conclusions appear without editor verification against the primary source.
Every article is reviewed by a named editor before publication. Source citations are listed in the References section. This content does not represent the views of any pharmaceutical company, medical device manufacturer, or healthcare provider.
References
1. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20-S42. doi:10.2337/dc24-S002
2. Cryer PE. Hypoglycemia in type 2 diabetes: an all too frequent complication. Diabetes Care. 2005;28(12):2996-2997. doi:10.2337/diacare.28.12.2996
3. Ma Y, Ma X, Wang Y, et al. Acupuncture for type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. J Tradit Chin Med. 2015;35(4):393-402.
4. Vickers AJ, Vertosick EA, Lewith G, et al. Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis. J Pain. 2018;19(5):455-474. doi:10.1016/j.jpain.2017.11.005
5. Zhao L, Chen J, Liu C, et al. A review of the neurobiological mechanisms of acupuncture for the treatment of diabetes mellitus. J Diabetes Res. 2017;2017:5093953. doi:10.1155/2017/5093953
6. Liang F, Koya D. Acupuncture and diabetes: from animal models to clinical evidence. Evid Based Complement Alternat Med. 2011;2011:673857. doi:10.1155/2011/673857
7. Zhang CS, Huang W, Zhang Y, et al. Acupuncture for type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2019;43:208-216. doi:10.1016/j.ctim.2019.01.018
8. MacPherson H, Hammerschlag R, Lewith G, et al. Acupuncture Research: Strategies for Improving Clinical and Scientific Rigor. J Altern Complement Med. 2016;22(10):760-765. doi:10.1089/acm.2016.0101
9. Wang J, Zhang Y, Yang H, et al. Current status and future directions of acupuncture research for diabetes mellitus. J Diabetes Res. 2020;2020:8876402. doi:10.1155/2020/8876402
